Quipt Home Medical Corp. Quality Score

QIPT

⊜ Compare

Quality11

Weak across most dimensions. This doesn't mean avoid, but the burden of proof is on the bull case.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Growth

Revenue Growth

70/100

7.8%

5–10% CAGR, steady but not exceptional

Cash Flow Growth

0/100

-4.1%

Below 2%, essentially flat

Business Quality & Capital Allocation

Share Dilution

0/100

13.0%

Heavy dilution above 5%

Margin Trend

0/100

-2.6pp

Contracted >2pp, margin pressure

Capital Structure

0/100

$93M

Net debt/FCF of 3.5x, high leverage

2023

$17.0M

$98.0M

2024

$16.0M

$95.0M

2025

$13.0M

$108M

TTM

$11.0M

$103M

CashDebt

Return on Capital

0/100

-1.3%

Below 8%, may not cover cost of capital

Customize WeightsPremiumAdjust metric weights to match your investment style.Upgrade

SourceQuality score computed from the 10-Q filed 6 Feb 2026, covering the period ending 31 Dec 2025, as reported to the SEC. Data last refreshed 13 Jun 2026. How this is calculated.

Fiscal year ends Sep. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.

Peers

Services-Misc Health & Allied Services, NEC · Pick stocks to compare with QIPT

CompareIntrinsic value

VMDViemed Healthcare Inc.

$10.11+6.93%82

CCELCryo-Cell International Inc.

$5.07+0.40%44

SHCSotera Health Company

$16.39+2.25%57

PGNYProgyny Inc.

$30.10+3.58%89

CONConcentra Group Holdings Inc.

$41.06+2.27%57

OMDAOmada Health, Inc.

$19.43+4.57%64

TALKTalkspace Inc.

No recent price40

SRTAStrata Critical Medical, Inc.

$5.22+17.57%55

Spot a number that looks wrong? Check it in QIPT's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing QIPT

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.